BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang Q, Lao X, Huang J, Zhu Z, Pang L, Tang Y, Song Q, Huang J, Deng J, Deng N, Yang Q, Sengupta AM, Xiong L. Soluble production and function of vascular endothelial growth factor/basic fibroblast growth factor complex peptide. Biotechnol Prog 2015;31:194-203. [PMID: 25271020 DOI: 10.1002/btpr.1997] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
Number Citing Articles
1 Zhang D, Tan QW, Luo JC, Lv Q. Evaluating the angiogenic potential of a novel temperature-sensitive gel scaffold derived from porcine skeletal muscle tissue. Biomed Mater 2018;13:055003. [PMID: 29724961 DOI: 10.1088/1748-605X/aac275] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
2 Xie H, Shu C, Bai H, Sun P, Liu H, Qi J, Li S, Ye C, Gao F, Yuan M, Chen Y, Pan M, Yang X, Ma Y. A therapeutic HPV16 E7 vaccine in combination with active anti-FGF-2 immunization synergistically elicits robust antitumor immunity in mice. Nanomedicine 2020;29:102254. [PMID: 32615335 DOI: 10.1016/j.nano.2020.102254] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Cai Y, Yao S, Zhong J, Zhang J, Jiang H, Deng Y, Deng N. Inhibition activity of a disulfide-stabilized diabody against basic fibroblast growth factor in lung cancer. Oncotarget 2017;8:20187-97. [PMID: 28423625 DOI: 10.18632/oncotarget.15556] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
4 Zhang Q, Lao X, Huang J, Zhu Z, Pang L, Tang Y, Song Q, Huang J, Deng J, Deng N, Yang Q, Sengupta AM, Xiong L. Corrections to: Soluble production and function of vascular endothelial growth factor/basic fibroblast growth factor complex peptide. Biotechnol Prog 2022;:e3246. [PMID: 35257519 DOI: 10.1002/btpr.3246] [Reference Citation Analysis]
5 Bolten SN, Knoll AS, Li Z, Gellermann P, Pepelanova I, Rinas U, Scheper T. Purification of the human fibroblast growth factor 2 using novel animal-component free materials. J Chromatogr A 2020;1626:461367. [PMID: 32797846 DOI: 10.1016/j.chroma.2020.461367] [Reference Citation Analysis]
6 Zahedipour F, Zamani P, Jamialahmadi K, Jaafari MR, Sahebkar A. Vaccines targeting angiogenesis in melanoma. Eur J Pharmacol 2021;912:174565. [PMID: 34656608 DOI: 10.1016/j.ejphar.2021.174565] [Reference Citation Analysis]
7 Taktak-BenAmar A, Morjen M, Ben Mabrouk H, Abdelmaksoud-Dammak R, Guerfali M, Fourati-Masmoudi N, Marrakchi N, Gargouri A. Expression, purification and functionality of bioactive recombinant human vascular endothelial growth factor VEGF165 in E. coli. AMB Express 2017;7:33. [PMID: 28168572 DOI: 10.1186/s13568-016-0300-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
8 Khan KA, Bicknell R. Anti-angiogenic alternatives to VEGF blockade. Clin Exp Metastasis 2016;33:197-210. [PMID: 26620208 DOI: 10.1007/s10585-015-9769-3] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.9] [Reference Citation Analysis]